A systems biology-informed machine learning framework to predict drug response using clinically available NGS data TYSONS, Va.–(BUSINESS WIRE)–Zephyr AI, Inc. (“Zephyr AI”), a company building novel transparent AI to address unmet needs across the full spectrum of precision medicine – from prevention to treatment to improve patients’ lives announced today a poster presentation at the […]
Zephyr AI’s machine learning algorithms identify pharmacological sensitivities and genetic vulnerabilities that fall outside the current single nucleotide variants or proteins that are typically used to identify patients that would respond to targeted therapies. Zephyr AI’s algorithms generate interpretable drug response predictions from real-world data (RWD) which are then validated with proven models.
 with RWD for Label Expansion with Approved 3rd G){kind=link}